DJIA 17,131.97 100.83 0.59%
NASDAQ 4,552.76 33.86 0.75%
S&P 500 1,998.98 14.85 0.75%
market minute promo

Incyte Corp (NASDAQ: INCY)

48.70 1.07 (2.25%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INCY $48.70 2.25%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.87
Previous Close $47.63
Daily Range $47.24 - $48.81
52-Week Range $33.01 - $70.86
Market Cap $8.2B
P/E Ratio -55.38
Dividend (Yield) $0.00 (0.0%)
Volume 836,581
Average Daily Volume 780,313
Current FY EPS -$0.32

Sector

Healthcare

Industry

Drugs

Incyte Corp (INCY) Description

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Website: http://www.incyte.com/

News & Commentary

3 Longtime Losers About to See Green?

These 3 biotechs have lost tons of money every year so far in the 21st century. But could profits be on the horizon?

SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks

Gilead: Let's Make A Deal

Earnings Estimates Moving Higher for Incyte Corporation (INCY): Time to Buy? - Tale of the Tape

Earnings Estimates Moving Higher for Incyte Corporation (INCY): Time to Buy? - Tale of the Tape

Bullish Two Hundred Day Moving Average Cross - INCY

3 Drugs Stocks Dragging The Industry Down

Incyte Posts Wider-than-Expected Q2 Loss, Raises Sales View - Analyst Blog

Incyte Posts Wider-than-Expected Q2 Loss, Raises Sales View - Analyst Blog

Incyte's (INCY) CEO Hervé Hoppenot on Q2 2014 Results - Earnings Call Transcript

Q2 2014 Incyte Corp Earnings Conference Call (Webcast)

Why Incyte (INCY) Might Surprise This Earnings Season - Tale of the Tape

UPDATE: Incyte Partners With Genetech to Help With Trials

See More INCY News...

INCY's Top Competitors

INCY $48.70 (2.25%)
Current stock: INCY
CELG $92.57 (3.48%)
Current stock: CELG
AMGN $139.33 (0.99%)
Current stock: AMGN
BIIB $326.88 (2.11%)
Current stock: BIIB